Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
T cell phenotype and clonality changes in myeloma patients with short overall survival
Alenka Djarmila Behsen, … , Anne Marit Sponaas, Kristine Misund
Alenka Djarmila Behsen, … , Anne Marit Sponaas, Kristine Misund
Published April 29, 2025
Citation Information: JCI Insight. 2025;10(11):e181096. https://doi.org/10.1172/jci.insight.181096.
View: Text | PDF
Research Article Hematology Immunology Oncology

T cell phenotype and clonality changes in myeloma patients with short overall survival

  • Text
  • PDF
Abstract

Overall survival (OS) in multiple myeloma (MM) varies between a couple of months to more than 20 years, influenced by tumor characteristics, the tumor microenvironment (TME), and patient factors such as age and frailty. We analyzed sequential BM samples from 45 MM patients with OS less than 3 years versus more than 8 years using mass cytometry and bulk TCRβ sequencing. Patients with long OS demonstrated stability in the TME and T cell environments, while those with short OS had significant changes at relapse, including fewer T cells, increased Tregs, and more activated and exhausted CD8+ T cells. Notably, higher programmed cell death 1 expression in CD8+ T cells at diagnosis correlated with short OS. Additionally, short-OS patients exhibited a more monoclonal T cell environment at relapse, with abundance of hyperexpanded clones. These findings reveal distinct immune cell differences between patients with short and long OS.

Authors

Alenka Djarmila Behsen, Esten Nymoen Vandsemb, Tobias Schmidt Slørdahl, Karen Dybkær, Maja Zimmer Jakobsen, Muhammad Kashif, Johan Lund, Vincent Luong, Astrid Marta Olsnes, Anders Waage, Anne Marit Sponaas, Kristine Misund

×

Figure 5

Increased CD8+ T cell exhaustion in myeloma patients with short survival.

Options: View larger image (or click on image) Download as PowerPoint
Increased CD8+ T cell exhaustion in myeloma patients with short survival...
(A) Heatmap showing the transformed ratio by column’s minimum MMI of selected markers for 7 populations (FlowSOM clustering using equal sampling and hierarchical consensus clustering) (left) and overlaid uniform manifold approximation and projection (UMAP) of the clusters found by FlowSOM analysis (right). TOX, thymocyte selection-associated high mobility group box protein; TIGIT, T cell immunoreceptor with immunoglobulin and ITIM domains. (B) Percentage of exhausted CD8+ TEM cells, as found by FlowSOM clustering, within the CD8+ T cell population. (C) Percentage of TOX+CD8+ T cells within the CD8+ T cell population, including age-matched HCs (n = 6), and (D) percentage of PD-1–TIGIT–TOX+CD8+ T cells (left) and PD-1+TIGIT+TOX+CD8+ T cells (right) within the TOX+CD8+ T cell population, as found by manual gating. Diagnosis and all available relapse samples were used for FlowSOM clustering. Heatmap and UMAP shown for a representative experiment. Paired diagnosis and last relapse samples from n = 11 long-OS patients and n = 10 short-OS patients are included in the bar graph. Mean ± SEM shown. Statistical significance was determined by repeated measures 2-way ANOVA and Šidák’s multiple comparisons test on long-OS and short-OS patient samples. Data from HCs are also shown. P values are indicated where P < 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts